ArticleScience advances2022

EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer.

Xiaoping Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.